Is iRhythm Holdings (IRTC) Undervalued Ahead Of Its November 5 Results?

iRhythm Holdings (IRTC) has marked November 5, 2026 as a key date, with third quarter results and a same-day conference call that could influence how investors view this cardiac monitoring specialist.

Over the past week, iRhythm Holdings has seen a 7 day share price return of 6.58%, although the 30 day share price return is down 2.26% and the year to date share price return is down 37.59%. However, the 5 year total shareholder return of 55.26% reflects a very different long term picture.

Scan how iRhythm Holdings compares to other cardiac and medtech players that also screen for resilience and quality by starting with our curated list of list of solid balance sheet and fundamentals (25 results).

iRhythm Holdings trades at a sizeable discount to both analyst targets and some intrinsic value estimates after a sharp year to date share price drop. Is that gap a sign of warranted caution, or an opportunity that depends on future execution?

Most Popular Narrative: 39% Undervalued

The most followed narrative values iRhythm Holdings at $178.93 per share, well above the recent $109.35 close. This sets a clear tension between current pricing and the long term story analysts are building around the Zio platform.

Investment in the Zio ecosystem, including next-generation patches, enhanced form factors, and AI-powered analytics (such as the Lucem Health partnership), is improving product differentiation, diagnostic yield, and workflow efficiency. This is likely leading to higher gross margins and operating leverage as software and data become a larger component of the business.

See why 4 investors see iRhythm Holdings as 39% undervalued.

Result: Fair Value of $178.93 (UNDERVALUED)

Still, the iRhythm Holdings story hinges on sensitive pressure points, with regulatory scrutiny and ongoing profitability challenges both capable of undermining the upbeat valuation narrative.

Find out about the key risks to this iRhythm Holdings narrative.

Another View On iRhythm Holdings Valuation

On the multiples side, iRhythm Holdings trades on a P/S ratio of 4.4x, above both the peer average of 2.9x and the US Medical Equipment industry at 2.5x, yet close to a fair ratio of 4.7x. That mix of premium pricing and fair ratio support raises a simple question. How much room is really left for comfort if sentiment shifts?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Conflicted by the mixed tone around iRhythm Holdings, with upside potential on one side and clear pressure points on the other? Act while sentiment is still forming and weigh both sides by reviewing the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond iRhythm Holdings?

Do not stop with iRhythm Holdings. Put this research in context by lining it up against a broader watchlist of opportunities that match your risk and income goals.

• Spot potential deep value setups early by scanning 33 high quality undervalued stocks that combine strong fundamentals with pricing that may have fallen out of favor.
• Prioritize resilience and sleep-at-night confidence by filtering for a 32 resilient stocks with low risk scores that can help steady your overall portfolio.
• Seek tomorrow's potential standouts before the crowd notices by reviewing a curated pool of 20 high quality undiscovered gems with solid underlying business quality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com